Evidence map›Paper›PMID 33736617›Full record

Trial reportBMC women's health2021

Group meta-cognitive therapy and depression in women with breast cancer: a randomized controlled trial.

Elham Zahedian, Masoud Bahreini, Nezamaddin Ghasemi, Kamran Mirzaei

Open access · goldAbstract readRandomized Controlled Trial
In one paragraph

Trial report in BMC women's health, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed, 1 pooled it
1.3field-weighted citation impact, top 19% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 1 synthesis or guideline pooled it, 15 citations in OpenAlex.

  1. Psychological interventions for women with non-metastatic breast cancer.The Cochrane database of systematic reviews · 2023
    Pooled it
  2. Article
  3. Article
  4. Review
  5. Article
  6. Article
  7. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 2 institutions in 1 country.

Elham ZahedianNursing and Midwifery School, Bushehr University of Medical Sciences, Bushehr, Iran.ORCID 0000-0003-3046-7819
Masoud BahreiniNursing and Midwifery School, Bushehr University of Medical Sciences, Bushehr, Iran. m.bahreini@bpums.ac.ir.ORCID 0000-0002-0178-747X
Nezamaddin GhasemiDepartment of Psychology, Salman Farsi University of Kazerun, Kazerun, Iran.ORCID 0000-0003-3707-7864
Kamran MirzaeiCommunity Medicine, Medical School, Bushehr University of Medical Sciences, Bushehr, Iran.ORCID 0000-0003-3551-1866
Bushehr University of Medical Sciences · IRSalman Farsi University of Kazerun · IR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundBreast cancer is one of the most common cancers in Iranian women. They will experience a mental health problem like depression before, during or after treatment. This study aimed to determine the effectiveness of group metacognitive therapy on depression, cognitive-emotional regulation, and meta-cognitive beliefs in women with breast cancer.

methodsIn this randomized controlled clinical trial, a total of 24 depressed patients with breast cancer were randomly allocated to experimental and control groups. The experimental group received meta-cognitive therapy in 8 weekly sessions, but the control group received treatment as usual. Beck Depressive Inventory, cognitive emotion regulation questionnaire, and meta-cognitions questionnaire were completed before, after and one month after the intervention. Data were analyzed using Wilcoxon and Chi-square tests.

resultsThe mean score of depression in the experimental group was reduced from 21.6 ± 4.83 in the pre-test to 13.83 ± 8.12 in one-month follow-up (p = 0.16); however, there was no significant difference in the control group. The mean score of cognitive emotion regulation did not show a significant change in the two groups during the study and follow-up period. The mean score of meta-cognitive beliefs reached 68.75 ± 15.74 from 79.51 ± 10.72 in the experimental group during the follow-up period (p = 0.006); however, there was no significant difference in the control group in the score of metacognitive beliefs.

conclusionThese findings support the efficacy of meta-cognitive therapy as a viable psychosocial intervention in depressed patients with breast cancer. Trial registration IRCT201606288473N5. Registered on: 05/09/2016 https://www.irct.ir/trial/8946 .

Indexed as

Breast NeoplasmsCognitive Behavioral TherapyPsychotherapy, GroupDepressionFemaleHumansIranTreatment OutcomeBreast cancerCognitive emotion regulationDepressionMetacognitive beliefsMeta-cognitive therapy

Identifiers

PMID33736617
PMCPMC7977266
OpenAlexW3139058081

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.